Status:
ACTIVE_NOT_RECRUITING
Parental Decision-Making for Children With Relapsed Neuroblastoma
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Relapsed Neuroblastoma
Eligibility:
All Genders
18+ years
Brief Summary
Parental decision-making for children with advanced cancer is complex. Many parents have overly optimistic beliefs about prognosis and as a result choose aggressive measures even at the end of life, w...
Detailed Description
Parental decision-making for children with advanced cancer is complex. Many parents have overly optimistic beliefs about prognosis and as a result choose aggressive measures even at the end of life, w...
Eligibility Criteria
Inclusion
- Parent of a child with relapsed or refractory high risk neuroblastoma, as defined by the International Neuroblastoma Risk Group, without respect to timing of first determination of relapse or refractory disease;
- Parent aged 18 years or older, of a child aged \<=18 years;
- English- or Spanish-speaking.
Exclusion
- Delirium/dementia as judged by the treating physician
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2027
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT02282735
Start Date
May 1 2013
End Date
June 1 2027
Last Update
July 29 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Los Angeles
Los Angeles, California, United States, 90027
2
Stanford/Packard's Children's Hospital
Palo Alto, California, United States, 94304
3
The University of Chicago Medical Center
Chicago, Illinois, United States, 60637
4
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215